Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2010
12/09/2010US20100310464 Antibodies
12/09/2010US20100310463 Anti-EpCAM Antibodies
12/08/2010EP2257808A1 Viral inactivation process
12/08/2010CN1893973B Methods for porducing storage stable viruses and immunogenic compositions thereof
12/08/2010CN1624135B DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
12/08/2010CN1384884B Herpes virus vectors for dendritic cells
12/08/2010CN101909635A Novel vaccines against multiple subtypes of dengue virus
12/08/2010CN101906423A Preparation method of recombined human nerve growth factor based on insect baculovirus expression system
12/08/2010CN101906404A Avian infectious bronchitis virus (IBV) as well as culture method and application thereof
12/08/2010CN101906403A Enterovirus and application thereof
12/08/2010CN101905020A Method for producing swine fever vaccines
12/08/2010CN101905019A Porcine hemagglutinating encephalomyelitis cell culture inactivated vaccine and preparation method thereof
12/08/2010CN101440359B Avian influenza viral vaccine and preparation thereof
12/08/2010CN101376880B Recombinant new castle disease LaSota attenuated vaccine strain expressing rabies virus glucoprotein (GP protein)
12/07/2010US7846729 Metabolically activated recombinant viral vectors and methods for their preparation and use
12/07/2010US7846710 cell comprising a polypeptide comprising a carboxy-terminal portion of a split intein (C-intein), an amino-terminal portion of a split intein (N-intein), and a target peptide; utilize the trans-splicing ability of split inteins to catalyze cyclization of peptides from a precursor peptide
12/07/2010US7846687 Modified viral sequences which enhance genic expression in microorganismal host
12/07/2010US7846663 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
12/07/2010US7846655 Diagnosing respiratory system infections via presence presence of viral RNA sequences; enzyme inhibitors; viricides
12/07/2010US7846455 Major nucleocapsid protein, nucleocapsid phosphoprotein,large polymerase protein, a m2 (orf1) rna polymerase elongation factor, and a rsv genome or antigenome of human rsv strain or subgroup virus combined with a heterologous gene
12/07/2010US7846454 nucleotide sequences which encode infectious hepatitis C viruses, for development of vaccines and diagnostics for HCV and in the development of screening assays for the identification of antiviral agents for HCV
12/07/2010CA2398335C Herpes virus strains
12/07/2010CA2262406C Gene therapy for congestive heart failure
12/02/2010WO2010138885A2 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
12/02/2010WO2010138675A1 Simian adenovirus 41 and uses thereof
12/02/2010US20100305199 Therapeutic regimen for treating cancer
12/02/2010US20100305136 Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
12/02/2010US20100304392 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
12/02/2010US20100303856 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
12/02/2010US20100303839 Methods and compositions for treatment of cancer using oncolytic rsv activity
12/02/2010US20100303730 Methods of making iron-containing nanoparticles
12/02/2010CA2763485A1 Methods for treating cancer and non-neoplastic conditions
12/02/2010CA2762203A1 Simian adenovirus 41 and uses thereof
12/01/2010EP2254993A1 Protein nanocarriers, process for obtaining them and applications
12/01/2010EP2254992A1 Novel tool for the analysis of neural circuits
12/01/2010EP1625210B1 Methods for producing preparations of recombinant aav virions substantially free of empty capsids
12/01/2010EP1513552B1 Packaged virus-like particles in combination with cpg for use as adjuvants with allergens : method of preparation and use
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1763181B Vaccine against mumps containing a JERYL-LYNN virus strain
12/01/2010CN101903516A A process for preparing attenuated viral strains
12/01/2010CN101899466A Dengue virus and Japanese encephalitis virus embedded pseudo virus particle vaccine and preparation method thereof
12/01/2010CN101899465A Recombinant J subgroup avian leucosis virus infective cloned plasmids and preparation method and application thereof
12/01/2010CN101899422A Adaptive culture method of rotavirus P(2) G3 strain and P(8) G1 strain on KMB17 cells and immunogenicity
12/01/2010CN101899421A Recombinant baculovirus and construction method and application thereof
12/01/2010CN101899420A Method for preparing dual-regulated oncolytic adenovirus for expressed superantigen gene of targeted prostate tumor
12/01/2010CN101899419A Insect baculovirus expression system and method for expressing E2 protein using same
12/01/2010CN101899418A Avian influenza virus (AIV) as well as kit and vaccine used for detecting and preventing same
12/01/2010CN101899417A Adefovir resistant mutant virus strain of hepatitis B virus and application thereof
12/01/2010CN101897963A Vaccine for hand-foot-and-mouth disease viruses
11/2010
11/30/2010US7842798 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s); vaccines
11/30/2010US7842298 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand
11/30/2010US7842295 Canine influenza virus and related compositions and methods of use
11/25/2010WO2010135704A2 Secretion-related bacterial proteins for nlrc4 stimulation
11/25/2010WO2010135054A2 Mutations in a toll-like receptor motif in the ns4b of classical swine fever virus skin brescia influences virulence in swine
11/25/2010WO2010134975A2 Methods for enhancing infectivity of retroviruses
11/25/2010WO2010134526A1 Vector material for creating pluripotent stem cells, and pluripotent stem cell creation method using said vector material
11/25/2010WO2010048615A3 Human ebola virus species and compositions and methods thereof
11/25/2010US20100297733 Systems And Methods For The Capture And Separation Of Microparticles
11/25/2010US20100297732 Vectors with modified protease-dependent tropism
11/25/2010US20100297731 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
11/25/2010US20100297730 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
11/25/2010US20100297606 IgG BINDING PEPTIDE
11/25/2010US20100297604 Methods and reagents for virus isolation and detection
11/25/2010US20100297177 Mutated parvovirus structural proteins as vaccines
11/25/2010US20100297175 Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine
11/25/2010US20100297174 Influenza virus vaccines and uses thereof
11/25/2010US20100297172 Replication-defective arenavirus vectors
11/25/2010US20100297167 Method for the Production of Recombinant Virus, DNA Constructs, Recombinant Virus and Vaccine Compositions
11/25/2010US20100297126 Monoclonal Antibodies Specific to Hemagglutinin from Influenza Virus H5-Subtype and Uses Thereof
11/25/2010US20100297085 Synthetic Herpes Simplex Viruses Type-1 for Treatment of Cancers
11/24/2010EP2253709A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/24/2010EP2253704A1 Oligonucleotide mediated nucleic acid recombination
11/24/2010EP2253701A1 Method of extracting virus from cell culture
11/24/2010EP1576143B1 Virus-like particles, methods of preparation, and immonogenic compositions
11/24/2010CN1513553B Vero cell fick-borne encephalitis inactivated vaccine
11/24/2010CN101892261A Recombinant adenovirus carrier and application thereof
11/24/2010CN101892202A Biotin labeling method of envelope viruses
11/24/2010CN101892201A Method for inoculating tomato yellow leaf curl virus by using injector to inject
11/24/2010CN101205539B Highly pathogenic PRRS virus recombinant plasmid and genetic engineering vaccines
11/23/2010US7838277 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells
11/23/2010US7838019 Use of iscom particle(s) as adjuvant in a formulation of vaccine antigens, which comprise at least one iscom-iscom matrix particle together with a non-replicating vaccine antigen and one or more living micro-organisms; enhanced immune response against live vaccine components
11/23/2010US7838006 Viral vaccine composition, process and methods of use
11/23/2010US7838001 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses
11/23/2010CA2567336C Inactivation of a pathogen in a sample by a treatment with formalin and uv light
11/23/2010CA2222140C Packaging systems for human recombinant adenovirus to be used in gene therapy
11/18/2010WO2010132886A1 Compositions and methods relating to xmrv-related diseases and conditions
11/18/2010WO2010131747A1 Virus-producing cell
11/18/2010WO2010130756A1 Immortalized avian cell lines and use thereof
11/18/2010WO2010130753A1 Method for orthopoxvirus production and purification
11/18/2010WO2010088626A3 Electricity generation using phototrophic microbial fuel cells
11/18/2010WO2010068939A3 Bioactive grafts and composites
11/18/2010US20100292166 PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT TUMORS CONTAINING HUMAN p31 GENES
11/18/2010US20100291546 Method for detection of hepatitis b virus
11/18/2010US20100291541 Bacteriophage immobilization for biosensors
11/18/2010US20100291538 Artificial calibration virus to control hiv viral load tests by pcr in real time
11/18/2010US20100291142 Bacterial Artificial Chromosome Containing Feline Herpes Virus Type 1 Genome and Uses Thereof
11/18/2010US20100291139 Recombinant mva virus and the use thereof
11/18/2010US20100291043 Il-12 immunotherapy for cancer
11/18/2010US20100291040 Virus-like particles for treatment of viral infections
11/18/2010US20100291035 Respiratory syncytial virus with a genomic deficiency complemented in trans
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 267